{
"id":"mk19_qq_q088",
"number":88,
"bookId":"qq",
"correctAnswer":"A",
"title":"Question 88",
"stimulus":[
{
"type":"p",
"hlId":"52c55d",
"children":[
"A 45-year-old woman is evaluated for a 4-month history of night sweats, fatigue, and a 4.1-kg (9-lb) weight loss."
]
},
{
"type":"p",
"hlId":"cabeb7",
"children":[
"Physical examination reveals conjunctival pallor, petechiae, and splenomegaly. ",
{
"type":"reference-range-link",
"referenceRange":"Hemoglobin, blood",
"children":[
"Hemoglobin"
]
},
" level is 8.1 mg/dL (81 g/L), ",
{
"type":"reference-range-link",
"referenceRange":"Leukocyte count",
"children":[
"leukocyte count"
]
},
" is 87,500/µL (87.5 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L), and ",
{
"type":"reference-range-link",
"referenceRange":"Platelet count",
"children":[
"platelet count"
]
},
" is 910,000/µL (910 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L). Peripheral blood smear shows neutrophilia and left-shifted granulopoiesis with no blasts. Fluorescence in situ hybridization assay is positive for (9;22) translocation."
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"413696",
"children":[
"Which of the following is the most likely diagnosis?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Chronic myeloid leukemia"
}
},
{
"letter":"B",
"text":{
"__html":"Essential thrombocythemia"
}
},
{
"letter":"C",
"text":{
"__html":"Leukemoid reaction"
}
},
{
"letter":"D",
"text":{
"__html":"Myelodysplastic syndrome"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"341e67",
"children":[
"Chronic myeloid leukemia is a clonal hematopoietic stem cell disorder characterized by translocation of the long arm of chromosomes 9 and 22 [t(9;22), Philadelphia chromosome], leading to a ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"BCR"
]
},
"-",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"ABL"
]
},
" fusion gene that promotes myeloid proliferation."
]
},
{
"type":"keypoint",
"hlId":"75e24c",
"children":[
"In chronic-phase chronic myeloid leukemia, the leukocyte count is high, the hemoglobin level is low or normal, and the platelet count is normal or high; the peripheral blood smear shows neutrophilia and left-shifted granulopoiesis."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"9c251d",
"children":[
"The most likely diagnosis is chronic myeloid leukemia (CML) (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option A"
]
},
"). CML is a clonal hematopoietic stem cell disorder characterized by translocation of the long arm of chromosomes 9 and 22 [t(9;22), Philadelphia chromosome], leading to a ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"BCR"
]
},
"-",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"ABL"
]
},
" fusion gene. This gene codes for an abnormal activated tyrosine kinase that promotes dysregulated cell proliferation, resulting in myeloid proliferation. CML consists of a chronic, an accelerated, and a blast phase. The diagnosis may be established incidentally, or patients may report symptoms including fatigue, night sweats, weight loss, abdominal discomfort, early satiety, and bleeding. On physical examination, splenomegaly is the most common finding. In chronic-phase CML, the leukocyte count is high, the hemoglobin level is low or normal, and the platelet count is normal or high. The peripheral blood smear shows neutrophilia and left-shifted granulopoiesis. Basophilia is common. An increasing proportion of blasts are seen as the disease progresses to more advanced phases."
]
},
{
"type":"p",
"hlId":"5ac5f9",
"children":[
"Essential thrombocythemia (ET) (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
") is suspected in patients with sustained elevation of platelet counts greater than 450,000/µL (450 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L). Diagnosis of ET requires ruling out other myeloproliferative neoplasms, such as CML, polycythemia vera, primary myelofibrosis, and myelodysplastic syndromes (MDSs). ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"JAK2"
]
},
" mutation is present in about 50% of patients with ET. Other clonal mutations in ET have been identified involving the calreticulin and ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"MPL"
]
},
" genes. Approximately one third of patients with ET will have splenomegaly. The presence of the ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"BCR-ABL"
]
},
" translocation between chromosomes 9 and 22 establishes the diagnosis of CML."
]
},
{
"type":"p",
"hlId":"8d0e37",
"children":[
"CML must be distinguished from leukemoid reactions (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option C"
]
},
") and other myeloproliferative disorders. Detection of the (9;22) translocation by routine cytogenetic studies or fluorescence in situ hybridization assay or of the ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"BCR-ABL"
]
},
" fusion transcript by reverse transcriptase polymerase chain reaction is diagnostic of CML and excludes a leukemoid reaction and other diagnoses. A leukemoid reaction usually is defined as a nonleukemic leukocytosis exceeding 50,000/µL (50 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L) and is characterized by an increase in early neutrophil precursors in the peripheral blood."
]
},
{
"type":"p",
"hlId":"463a90",
"children":[
"The MDSs (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
") are clonal hematopoietic progenitor cell disorders characterized by ineffective hematopoiesis and a variable rate of transformation to acute myeloid leukemia. Symptoms include fatigue and easy bleeding. Infections resulting from neutropenia are a common cause of death. Laboratory studies usually reveal normocytic/macrocytic anemia and other cytopenias. This patient's significant leukocytosis, thrombocytosis, and (9;22) translocation are not consistent with an MDS."
]
}
],
"relatedSection":"mk19_b_hm_s2_3_1",
"objective":{
"__html":"Diagnose chronic myeloid leukemia."
},
"references":[
[
"Spivak JL. Myeloproliferative neoplasms. N Engl J Med. 2017;376:2168-2181. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28564565",
"target":"_blank"
},
"children":[
"PMID: 28564565"
]
},
" doi:10.1056/NEJMra1406186"
]
],
"hospitalist":false,
"hvc":false,
"peerComparison":{
},
"hlIds":[
"52c55d",
"cabeb7",
"413696",
"341e67",
"75e24c",
"9c251d",
"5ac5f9",
"8d0e37",
"463a90"
]
}